Wealth Enhancement Advisory Services’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.22M Sell
15,922
-2,850
-15% -$1.32M 0.01% 765
2026
Q1
$8.52M Sell
18,772
-3,170
-14% -$1.62M 0.02% 661
2025
Q4
$13.4M Buy
21,942
+6,749
+44% +$3.83M 0.02% 596
2025
Q3
$8.08M Buy
15,193
+9,117
+150% +$3.98M 0.01% 740
2025
Q2
$1.95M Sell
6,076
-1,200
-16% -$360K ﹤0.01% 1362
2025
Q1
$2.22M Sell
7,276
-1,095
-13% -$368K ﹤0.01% 1192
2024
Q4
$2.78M Buy
8,371
+5,949
+246% +$2.02M 0.01% 1030
2024
Q3
$808K Buy
2,422
+1,079
+80% +$410K ﹤0.01% 1517
2024
Q2
$553K Buy
1,343
+694
+107% +$275K ﹤0.01% 1590
2024
Q1
$262K Buy
+649
New +$228K ﹤0.01% 2004

Other funds holding MEDP

Wealth Enhancement Advisory Services's MEDP Position: Q2 2026 in Review

Wealth Enhancement Advisory Services reduced its Medpace (MEDP) stake by 15% in Q2 2026, selling an estimated $1.32M and leaving 15,922 shares worth $8.22M. The position accounts for 0.01% of the portfolio, ranked #765.

Wealth Enhancement Advisory Services first reported a position in MEDP in Q1 2024 and has held it in 10 quarters since. The position peaked at $13.4M in Q4 2025. 78 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Wealth Enhancement Advisory Services held 15,922 shares of Medpace worth $8.22M as of Q2 2026.
  • Wealth Enhancement Advisory Services sold 2,850 Medpace shares in Q2 2026, an estimated $1.32M.
  • Medpace made up 0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #765 holding.
  • Wealth Enhancement Advisory Services first reported a position in Medpace in Q1 2024 and has held it in 10 quarters since.
  • Wealth Enhancement Advisory Services's Medpace position peaked at $13.4M in Q4 2025.
  • 78 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.